EGR1 and cardiovascular disorder: Catalytic and non-catalytic nucleic acid approaches, such as DNAzymes, miRNAs, and ODNs decoys, have been used to investigate the primary regulatory role of Egr-1 in cardiovascular diseases, using animal models and Egr-1-deficient mice.